Central venous catheter is a thin, flexible tube (catheter) that is placed into the large vein above the heart, usually through a vein in the neck, chest, or arm. It’s also called the central venous line or central line. Central venous catheters are used to administer chemotherapy drugs, intravenous (IV) fluids, antibiotics, blood and platelet transfusions, parenteral nutrition, etc. The peripherally inserted catheter is the commonly used central venous catheter due to several advantages such as easy to insert and remove, easy to repair. Central venous catheters need special care. They may require regular cleaning or dressing employing sterile techniques. Central venous access is a commonly performed procedure with about 8% of hospitalized patients needing central venous access during the course of their hospital stay. More than five million central venous catheters are inserted in the U.S. each year.
Rising adoption and increasing demand for antimicrobial-coated catheters, rising number of chronic diseases such as cancer, end-stage renal disease and others, increasing geriatric population, and rising usage of tip location devices are anticipatead to drive the global central venous catheter market. Other factors such as favorable insurance and reimbursement policies, technological innovation, and early adoption of diagnostic procedures are likely to fuel the overall central venous catheter market. According to the U.S. Department of Health and Human Services, national expenditures for cancer treatment in the U.S. was nearly US$ 125 billion in 2010 and is estimated to reach US$ 156 billion by 2020. On the other hand, the risks associated with catheters and pricing pressure are projected to hinder the expansion of the global central venous catheter market.
The central venous catheter market has been segmented based on product type, route of insertion, application, end-user and region. In terms of product type, the market can be segmented into peripherally-inserted central catheter (PICC), non-tunneled catheters, tunneled catheter, and implanted port. In terms of route of insertion, the central venous catheter market can be segmented into intravenous and subcutaneous. Based on application, the central venous catheter market can be segmented into medication administration, administration of fluid and nutrition, transfusion of blood products, and diagnostic testing. In terms of end-user, the market can be segmented into hospitals, clinics, ambulatory surgery centers, and diagnostic centers.
In terms of region, the central venous catheter market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the global central venous catheter market due to technological advancement, rising prevalence of cancer, cardiovascular and end stage renal diseases, and rising geriatric population. According to the American Cancer Society, about 1,688,780 new cancer cases are expected to be diagnosed in 2017 in the U.S. Europe is the second largest market for central venous catheter due to increasing number of patients undergoing dialysis and transfusion of blood products, and rising lifestyle diseases. The central venous catheter market in Asia Pacific is estimated to expand at higher rate due to the large population base, high target patient pool, increasing government initiatives to provide better healthcare facilities, rising disposable income, and per capita health care expenditure. According to the World Health Organization, Singapore ranks sixth, globally, for its advanced healthcare system and offers the fourth best healthcare infrastructure in the world. Demand for advanced medical technologies is anticipated to strengthen its reputation as a healthcare hub in the region.
Major players operating in the global central venous catheter market include B. Braun Melsungen AG, Becton, Dickinson and Company, C. R. Bard, Cook Medical, Teleflex Incorporated, Siemens Healthineers, and AngioDynamics, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.